Clinical application of acupuncture myofascial trigger points in the treatment of postherpetic neuralgia and analysis of influencing factors.

Researchers studied whether combining acupuncture at myofascial trigger points with standard medication (gabapentinoids) works better than medication alone for treating postherpetic neuralgia—the persistent nerve pain that can follow a shingles outbreak. The study included 494 patients randomly divided into two groups: one receiving only medication and another receiving both acupuncture and medication. Pain levels were measured at the start, after 3 weeks, and after 6 weeks using a standard pain scale. Both groups experienced significant pain relief, but patients receiving the combination treatment reported notably greater improvement at both the 3-week and 6-week marks. The researchers also found that certain factors influenced how well patients responded to treatment: older patients and those with higher body weight tended to experience less pain relief, while patients with chest or back pain showed the best results. This suggests that acupuncture targeting trigger points may provide additional short-term benefit beyond medication alone for shingles-related nerve pain, though the study had some limitations that prevent drawing definitive conclusions about cause and effect. The findings indicate that treatment response may vary based on individual characteristics like age, weight, and pain location, suggesting personalized approaches may be beneficial. If you're considering acupuncture for postherpetic neuralgia, consult with a licensed acupuncturist experienced in pain management to determine if this approach is appropriate for your situation.

This randomized trial (n=494) compared myofascial trigger point acupuncture plus gabapentinoids versus gabapentinoids alone for postherpetic neuralgia management. Patients were assessed using the Numerical Rating Scale at baseline, week 3, and week 6. The combination therapy group demonstrated statistically significant greater pain reduction at both week 3 and week 6 compared to pharmacotherapy alone (P<0.001). Multivariate regression analysis identified independent prognostic factors associated with treatment response: advanced age and elevated BMI correlated with diminished pain reduction at both timepoints, while thoracic pain location predicted superior outcomes at week 6. The study's observational design with baseline imbalance and absence of sham control limits causal inference regarding acupuncture efficacy. Clinical implications suggest myofascial trigger point needling may provide adjunctive short-term analgesic benefit, with response heterogeneity based on patient demographics and pain distribution. Individualized treatment strategies considering age, BMI, and dermatomal involvement may optimize outcomes.